Download presentation
Presentation is loading. Please wait.
Published byLillian Wade Modified over 6 years ago
1
LEPROSY Professor Jamal R Al-Rawi MBChB, MSc, FICMS
Prof. of Comm. Med. & Dermatovenereology Dept of Comm. Med. College of Med. Al-Mustansiriya University.
2
Leprosy Hansen’s Disease
Definition: Infectious agent: Mycobacterium Leprae Resistance Classification Viability Virulence Multiplications Inactivation Antigenicity
3
LEPROSY (Hansen’s Disease)
Epidemiology A- Geographical Distribution B- Prevalence C- Age distribution D- Sex Distribution E- Occupation F- Seasonal Variation
4
LEPROSY- CLINICAL FORMS
Closed case Open case Low infectivity High infectivity Paucibacillary Multibacillary TT BT BB BL LL Tuberculoid Leprosy Lepromatous leprosy Drug therapy WHO Strategy Stimulate CMI Prof. Dr Jamal R Al-Rawi, MBChB, MSc, FICMS
5
Transplacental transmission Percutaneous Transmission
MODE OF TRANSMISSION Inhalation Transplacental transmission Percutaneous Transmission
6
Leprosy Hansen’s Disease
Control Measures: Reporting Isolation of case until 6 successive cultures it become negative. Proper disinfection of the patients towels utensils etc. examination of the contact & screening for positive cases. Treatment of contacts by chemoprophylaxis Preventive Measures Improvement of living condition BCG vaccination Screening for cases in area with high prevalence & among risk groups Eradications of endemic foci.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.